All In Biotech

Drug Trial Radar · NCT07073157

Effect of HRS-8427 for Injection on the Pharmacokinetics of Furosemide and Metformin in Healthy Subjects。

Last checked: Nov 20, 2026Latest source record: Aug 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

24

Actual

Start

Jul 15, 2025

Primary completion

Aug 15, 2025

Study completion Aug 15, 2025

Sponsor

Sponsor type
Industry
First posted
Jul 18, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The pharmacokinetics of HRS-8427 for injection on the transporter OAT1 substrate furosemide and the MATE1/METE2-K substrate metformin were evaluated in healthy subjects. The safety of HRS-8427 for injection was evaluated in combination with furosemide and metformin.

Conditions

  • Health Volunteer

Interventions

  • HRS-8427 injection plus furosemideDrug

    HRS-8427 injection plus furosemide

  • HRS-8427 injection plus metforminDrug

    HRS-8427 injection plus metformin

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. CmaxTime frame: The observation lasted until the 9th day
  2. AUC0-tTime frame: The observation lasted until the 9th day
  3. AUC0-∞Time frame: The observation lasted until the 9th day
  4. TmaxTime frame: The observation lasted until the 9th day
  5. t1/2Time frame: The observation lasted until the 9th day
  6. CL/FTime frame: The observation lasted until the 9th day
  7. Vz/FTime frame: The observation lasted until the 9th day

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Fujian Medical University

    Fuzhou, Fujian, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.